Prioritizing Return of Value: A Roadmap to Enhancing Biobanking Participation Among Black Women with Endometrial Cancer

The Critical Need for Inclusive Biobanking in Endometrial Cancer

Endometrial
**Formulating Initial Draft**

I’m now formulating the first draft, mapping the content to the headings provided. I’m expanding on the Return of Value (ROV) priorities in my mind, outlining how genetics and lifestyle results will be presented. The SISTER Study’s methodology is also being fleshed out, and I’m ensuring there is a strong emphasis on the importance of trust, and the 14 recommendations, for the clinicians.
cancer (EC) presents one of the most stark examples of racial health disparities in oncology. While the incidence of EC is rising across all demographics, Black women experience significantly higher mortality rates and are more likely to be diagnosed with aggressive, non-endometrioid histological subtypes compared to their white counterparts. Understanding the molecular drivers of these disparities is essential for developing precision medicine interventions. However, the scientific community faces a persistent hurdle: the underrepresentation of Black women in biobanking and translational research.